Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice.

Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Abstract Text:

    p x xingP X Xing,g poulosG Poulos,i f mckenzieI F McKenzie,

    Mucin-1 (MUC-1), which is overexpressed in more than 90% of human breast cancers, is a potential target for immunotherapy. To develop a mouse model appropriate for the immunotherapy of human cancer, mouse mucin-1 (muc-1) fusion protein, containing ten tandem repeats, was made and used to immunize C3H/HeOuj mice, which supposedly have a high incidence of breast cancer. C3H/HeOuj mice were injected eight times with 5 microg oxidized mannan muc-1-glutathione-S-transferase (MMFP) with or without cyclophosphamide, which is used to increase cellular immunity. At 80 age weeks, only 12.1% (4 of 33) mice of the untreated C3H/HeOuj mice had mammary tumors. The reason for the low incidence of breast cancer in these mice is not known, but all the mammary tumors were MUC-1+ breast adenocarcinomas and were transplantable to C3H/HeOuj mice. The incidence was 11.4% (4 of 35) in mice injected with MMFP: 38.2% (13 of 34) in mice given cyclophosphamide; and 14.3% (2 of 14) in mice treated with glutathione-S-transferase. That is, cyclophosphamide increased the incidence of mammary tumors, and metastases were found in only these mice. Fewer tumors (6 of 34 or 17.6% compared with 13 of 34 or 38.2% with cyclophosphamide only) occurred in the group immunized with MMFP and cyclophosphamide. Mice immunized with MMFP had high levels of muc-1 antibodies and cellular immune responses (the frequency of the precursor of the cytotoxic Tlymphocyte cell was 1 of 40,000 to 1 of 100,000), which were not found in control groups. The occurrence of muc-1 immunity, particularly the presence of large amounts of anti-mucin-1 antibodies, had no effect on tumor incidence. Thus, the immunization with murine muc-1 reduced the tumor incidence in only cyclophosphamide-treated mice and led to strong muc-1 antibody production and to cellular responses. These findings have implications for human tumor immunotherapy in which strong antibody and weak cellular responses are to be expected and, indeed, have been found.

    Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Publishing Authors By Initials

    px xingPX Xing,g poulosG Poulos,if mckenzieIF McKenzie,

    For similar peptides: peptide fragments research abstracts see: peptides: peptide fragments research

    PUBMED ID PMID:

    MEDLINE DATE: 2001 Jan-Feb

    Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

    VOLUME: 24

    Page Numbers: 10-8

    Journal Abbreviation: J. Immunother.

    ISSN: 1524-9557

    DAY: 1

    MONTH: 12

    YEAR: 2007

    Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9706083

    Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Keywords Mesh Terms:

    KEYWORDS: Peptide Fragments

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice. Information

    Substance Name: Cyclophosphamide

    Registry Number: 50-18-0

    Grant and Affiliation Information for Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice.

    AFFILIATION: The Austin Research Institute, Austin and Repatriation Medical Center, Heidelberg, Victoria, Australia.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Immunother (1997)

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Breast cancer in mice: effect of murine MUC-1 immunization on tumor incidence in C3H/HeOuj mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News